Welcome to our dedicated page for The Carlyle Group SEC filings (Ticker: CG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Carlyle Group Inc. (NASDAQ: CG) files a range of documents with the U.S. Securities and Exchange Commission that provide detail on its operations, financing, and governance as a global investment firm. This page aggregates Carlyle’s SEC filings and pairs them with AI-powered summaries to help readers understand the key points in each report.
Recent Form 8-K filings show how Carlyle uses the capital markets and discloses material events. One 8-K describes the company’s quarterly financial results, furnished through a summary earnings press release and detailed earnings presentation. Other 8-Ks filed in September 2025 outline the pricing and issuance of $800 million aggregate principal amount of 5.050% Senior Notes due 2035, the related senior notes indenture, and the guarantees provided by several Carlyle holding entities. These filings explain the terms of the notes, including interest rate, maturity, redemption provisions, and events of default.
Another Form 8-K filed in July 2025 details leadership changes effective January 1, 2026, including the planned appointment of three Co-Presidents and a new Chief Financial Officer. The filing describes how these roles align with Carlyle’s Global Private Equity, Global Credit and Insurance, and Global Client Business segments, and notes that these senior professionals invest in and alongside Carlyle funds as described in the company’s proxy statement.
On this SEC filings page, users can review Carlyle’s 8-K current reports, as well as other core filings such as annual reports on Form 10-K, quarterly reports on Form 10-Q, and registration statements when available. AI-generated highlights help explain complex sections, such as indenture covenants, guarantee structures, or executive compensation disclosures in proxy-related documents. The platform also surfaces real-time updates from EDGAR, allowing investors to see new filings as they are posted and to explore how Carlyle’s disclosures relate to its activities in private equity, credit, and investment solutions.
The Carlyle Group Inc. filed a Form 13F on behalf of multiple reporting managers reporting holdings aggregated across its group. The filing lists 20 information-table entries with a total market value of $10,619,090,498 and indicates 3 other included managers. The report is signed by General Counsel Jeffrey W. Ferguson on 05-08-2026.
The Carlyle Group Inc. reported a net loss for the quarter ended March 31, 2026, driven by negative investment performance allocations. Total revenues fell to $254.0 million from $973.1 million a year earlier, as performance allocations swung to a loss of $681.1 million from income of $222.9 million.
Fund management fees were relatively stable at $584.0 million versus $586.1 million, while incentive fees rose to $51.7 million from $43.2 million. Net loss attributable to Carlyle was $132.2 million, compared with net income of $130.0 million, resulting in diluted earnings per share of $(0.37) versus $0.35.
Total assets increased to $29,842.0 million from $29,116.0 million as of December 31, 2025, with cash and cash equivalents of $1,673.2 million. Shares of common stock outstanding were 359,974,427 as of May 5, 2026.
The Carlyle Group Inc. reported a U.S. GAAP loss before income taxes of $179 million for Q1 2026, leading to a net loss attributable to common stockholders of $132.2 million, or $(0.37) per diluted share. The loss was driven largely by investment losses, including performance allocations, which produced a margin on loss before income taxes of 70.5%.
On a non‑GAAP basis, Carlyle generated pre‑tax Distributable Earnings of $327 million, or $0.89 per common share after tax, with Fee Related Earnings of $300 million. Total assets under management reached $475 billion as of March 31 2026, up 5% year‑over‑year, and fee‑earning AUM was $333 billion, up 6%.
The Board declared a quarterly dividend of $0.35 per common share, payable May 28 2026 to shareholders of record on May 18 2026, and the company repurchased or withheld 3.8 million shares in Q1 2026 for $205 million. Available capital stood at $96 billion, and net accrued performance revenues were $2.6 billion as of March 31 2026.
Cherwoo Sharda reported acquisition or exercise transactions in this Form 4 filing.
Carlyle Group Inc. director Sharda Cherwoo received a grant of 4,450 shares of common stock in the form of restricted stock units at no cash cost as compensation. The award was made under The Carlyle Group Inc. Amended & Restated 2012 Equity Incentive Plan and will vest on May 1, 2027, if she continues serving on the Board through that date. Following this grant, she directly holds 20,398 shares of Carlyle common stock.
HANCE JAMES H JR reported acquisition or exercise transactions in this Form 4 filing.
Carlyle Group Inc. director James H. Hance Jr. received an equity award of 4,450 shares of Common Stock in the form of restricted stock units. The award was granted at no cash cost per share and is part of the company’s Amended & Restated 2012 Equity Incentive Plan.
The restricted stock units will vest on May 1, 2027, if he continues serving the company or its affiliates through that date. After this award, he holds a total of 316,538 shares of Carlyle Group Inc. common stock directly.
FILLER LINDA reported acquisition or exercise transactions in this Form 4 filing.
Carlyle Group Inc. director Linda Filler received a grant of 4,450 shares of common stock in the form of a restricted stock unit award under the company’s Amended & Restated 2012 Equity Incentive Plan. The award will vest on May 1, 2027, if she continues serving on the board through that date, and receipt of the vested shares is deferred to a future date under her deferral election. After this grant, she directly holds 26,163 shares of Carlyle Group common stock. This is a compensation-related equity award, not an open-market stock purchase or sale.
SHAW WILLIAM JOSEPH reported acquisition or exercise transactions in this Form 4 filing.
Carlyle Group Inc. director William Joseph Shaw received an equity-based compensation grant in the form of 4,450 shares of common stock on May 1, 2026. The award is structured as restricted stock units under The Carlyle Group Inc. Amended & Restated 2012 Equity Incentive Plan, with no cash purchase price.
The filing states these restricted stock units will vest on May 1, 2027, provided Shaw continues to serve on Carlyle’s Board of Directors through that date. After this grant, he directly holds a total of 78,093 shares of Carlyle common stock, reflecting his ongoing equity stake in the company.
Carlyle Group Inc. director Mark S. Ordan reported two equity awards of common stock. He received 4,450 restricted stock units under The Carlyle Group Inc. Amended & Restated 2012 Equity Incentive Plan, which will vest on May 1, 2027 if he continues serving on the Board.
He was also granted 4,450 vested shares of common stock under the same plan, received in lieu of his annual cash retainers for Board service. After these awards, his reported direct holdings in common stock were updated in the filing, reflecting these compensation-related acquisitions rather than open-market purchases.
WELTERS ANTHONY reported acquisition or exercise transactions in this Form 4 filing.
Carlyle Group Inc. director Anthony Welters reported receiving a grant of 4,450 shares of common stock in the form of restricted stock units. The award was granted at no cash cost per share and increased his directly held position to 47,849 shares after the transaction.
The restricted stock units were granted under The Carlyle Group Inc. Amended & Restated 2012 Equity Incentive Plan and are scheduled to vest on May 1, 2027, if he continues serving on the company’s Board of Directors through that date.
FITT LAWTON W reported acquisition or exercise transactions in this Form 4 filing.
Carlyle Group Inc. director Lawton W. Fitt received a grant of 4,450 shares of Common Stock in the form of a restricted stock unit award under The Carlyle Group Inc. Amended & Restated 2012 Equity Incentive Plan. These units will vest on May 1, 2027, subject to her continued service on the board, and receipt of the shares is deferred to a future date under her deferral election. After this award, she directly holds 78,093 shares of Carlyle common stock.